Patent Law Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Patent law is the primary means by which the government does what?

A

By which the gov promotes investment in and the development of new technologies and inventions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is patent law under attack?

A

Critics assert that it acts as a tax on innovation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The patent gives limited rights. which rights are limited?

A

Property rights

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the patent rights?

A

The holder has the right to exclude others from using the invention
the holder has positive rights to sell or license his invention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Benefits of patents

A

Encourages an inventor to create by giving inventor exclusive rights
encourages inventor to develop, license and sell the invention
good for society as a whole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cons of patents

A

Monopoly on invention can be bad for society since people can be excluded from benefiting from a technology/invention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2 main types of patents granted by US patent office

A

Design and Utility (more expensive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

4 elements for claiming a patent

A
  1. it must be the proper subject matter of a patent
  2. it must be novel
  3. useful
  4. non obvious
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

An invention is not patentable if

A
  1. the invention was known to the public before the applicant filed for patent protection
  2. the invention was described in a printed publication
  3. the invention was described in apublished patent publication or issued patent that was filed before the applicant filed for patent application
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diamond v. Chakrabarty. When and what?

A

(1980), was a United States Supreme Court case dealing with whether genetically modified organisms can be patented

In a 5–4 ruling, the court ruled in favor of Chakrabarty, holding that:

A live, human-made micro-organism is patentable subject matter under 35 U.S.C. § 101. Respondent’s micro-organism constitutes a “manufacture” or “composition of matter” within that statute.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Budapest Treaty

A

International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure

an international treaty signed in Budapest, Hungary, on April 28, 1977.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What makes biotech patents complicated?

A

Ethical and moral considerations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The following in particular shall not be regarded as inventions

A

(a) discoveries, scientific theories and mathematical methods;
(b) aesthetic creations;
(c) schemes, rules and methods for performing mental acts, playing games or doing business, and programs for computers;
(d) presentations of information.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 2 main hallmarks of cancer?

A
  1. Genetic and epigenetic changes

2. Microenvironment factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the Genetic and epigenetic changes in cancer

A
  1. Self-sufficiency in growth signals
  2. Insensitivity to growth-inhibitory signals
  3. Evading programmed cell death
  4. Limitless replication potential
  5. Sustained angiogenesis
  6. Invasion and metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the microenvironment factors in cancer

A
  1. Immune evasion
  2. Stress response
  3. Stromal subversion
  4. Cytokine factors
17
Q

What are the types of targeted cancer therapy?

A
  1. Small molecule drugs
  2. Monoclonal antibodies
Hormonal therapy
Signal transduction inhibitors
Gene expression modulators
Apoptosis inducers
Angiogenesis inhibitors
Immunotherapies